https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia" https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48375 Wed 15 Mar 2023 13:47:42 AEDT ]]> Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT⁺ cancers https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11381 Sat 24 Mar 2018 08:11:51 AEDT ]]>